Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment

Advanced Drug Delivery Reviews
Ayelet David

Abstract

Since their initial discovery more than 30years ago, tumor-homing peptides have become an increasingly useful tool for targeted delivery of therapeutic and diagnostic agents into tumors. Today, it is well accepted that cells at the tumor microenvironment (TME) contribute in many ways to cancer development and progression. Tumor-homing peptide-decorated nanomedicines can interact specifically with surface receptors expressed on cells in the TME, improve cellular uptake of nanomedicines by target cells, and impair tumor growth and progression. Moreover, peptide ligand-modified nanomedicines can potentially accumulate in the target tissue at higher concentrations than would small conjugates, thus increasing overall target tissue exposure to the therapeutic agent, enhance therapeutic efficacy and reduce side effects. This review describes the most studied peptide ligands aimed at targeting cells in the TME, discusses major obstacles and principles in the design of ligands for drug targeting and provides an overview of homing peptides in ligand-targeted nanomedicines that are currently in development for cancer therapy and diagnosis.

References

Dec 15, 1977·FEBS Letters·P CouvreurP Speiser
Sep 30, 1976·The New England Journal of Medicine·G Gregoriadis
Dec 1, 1990·Journal of Pharmaceutical Sciences·S AmselemY Barenholz
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S E CwirlaW J Dower
Sep 8, 1995·The Journal of Biological Chemistry·C L MartensC W Smith
Mar 28, 1996·Nature·R Pasqualini, E Ruoslahti
Aug 2, 1996·Journal of Medicinal Chemistry·M M JavadpourM L McLaughlin
Jun 1, 1997·Nature Biotechnology·R PasqualiniE Ruoslahti
Sep 2, 1999·Nature Medicine·H M EllerbyR Pasqualini
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·H MaedaK Hori
Feb 7, 2001·International Journal of Cancer. Journal International Du Cancer·A LatilR Lidereau
Jun 3, 2000·Annual Review of Immunology·E Ruoslahti, D Rajotte
Feb 15, 2001·Seminars in Cancer Biology·E Ruoslahti
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·J KopecekC M Peterson
Nov 22, 2001·The Journal of Biological Chemistry·Anthony J Day, Glenn D Prestwich
Feb 1, 2002·Nature Medicine·Wadih ArapRenata Pasqualini
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leonard W SeymourUNKNOWN Cancer Research Campaign Phase I/II Clinical Trials committee
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimmo PorkkaErkki Ruoslahti
Jun 8, 2002·Advanced Drug Delivery Reviews·Frank F Davis
Jun 8, 2002·Nature Medicine·Pirjo LaakkonenErkki Ruoslahti
Jul 31, 2002·The Journal of Biological Chemistry·Elias A SaidAra G Hovanessian
Aug 15, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jocelyn HolashJohn S Rudge
Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Maria E AkermanErkki Ruoslahti
Oct 3, 2002·Nature Reviews. Cancer·Theresa M Allen
Oct 10, 2002·The Journal of Biological Chemistry·Giorgio ColomboAngelo Corti
Nov 14, 2002·Pharmacological Reviews·Zhong Ming QianKwokping Ho
Nov 15, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giuseppe Giaccone
Dec 10, 2002·Trends in Molecular Medicine·Renata PasqualiniDonald M McDonald
Jan 25, 2003·Experimental Hematology·Ruiwu LiuKit S Lam

❮ Previous
Next ❯

Citations

Jul 30, 2019·Advanced Materials·Peng MiKazunori Kataoka
Sep 10, 2019·Expert Opinion on Drug Delivery·Sadia SikderDhananjay Pal
May 29, 2018·Archives of Pharmacal Research·Kyoung Ah MinMeong Cheol Shin
Feb 23, 2018·Journal of Nanobiotechnology·Christophe AlricEmilie Allard-Vannier
Sep 28, 2018·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Lies A L FliervoetTina Vermonden
Mar 25, 2019·Drug Delivery·Ningning SongJinhua Zhao
Dec 12, 2019·Journal of Drug Targeting·Farnaz KhodabakhshFatemeh Kazemi-Lomedasht
Dec 9, 2020·Advanced Materials·Mengyu ChangJun Lin
Nov 19, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Piotr GierlichLígia C Gomes-da-Silva
Nov 19, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marie RütterAyelet David
Oct 21, 2020·Advanced Drug Delivery Reviews·Ke LiXian-Zheng Zhang
Mar 17, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Ejaj AhmadSundeep Singh Saluja
Apr 30, 2021·International Journal of Pharmaceutics·Solmaz Mojarad-JabaliHadi Valizadeh
May 20, 2021·Macromolecular Bioscience·Marina Rodrigues TavaresTomáš Etrych
Sep 1, 2018·Biomacromolecules·Bing XueEugenia Kharlampieva
Aug 28, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Siao-Syun GuanShing-Hwa Liu
Aug 24, 2021·Carbohydrate Polymers·Asghar Narmani, Seid Mahdi Jafari
Aug 28, 2021·Entropy·Abderrahim BakakAbdelaziz Koumina
Aug 23, 2021·Biomarker Research·Lei DouHaifeng Dong
Aug 31, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Elham SeyyedniaHadi Valizadeh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR)
R Pasqualini
Bioconjugate Chemistry
Helena MyrbergUlo Langel
© 2022 Meta ULC. All rights reserved